価格表

在庫・価格 : 2024年05月08日 02時08分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
VIP, EIA Kit (96 well) <Vasoactive Intestinal Peptide, EIA Kit>
データシート※最新のデータシートでない場合があります
EK-064-16 PPEフェニックス ファーマシューティカルス
Phoenix Pharmaceuticals, Inc.
1 kit ¥156,000
(未発注)
追加

在庫・価格 : 2024年05月08日 02時08分 現在

VIP, EIA Kit (96 well) <Vasoactive Intestinal Peptide, EIA Kit>

  • 商品コード:EK-064-16
  • メーカー:PPE
  • 包装:1kit
  • 価格: ¥156,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Grimsholm O et al. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res. Ther. 2005;7(3):R416-26
Grimsholm O et al
2005/01/01
PubMed
2 Collado B et al. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. Mol. Cell. Endocrinol. 2006 Apr;249(1-2):116-22
Collado B et al
2006/01/01
PubMed
3 Sun W et al. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis. Int. Immunol. 2006 Dec;18(12):1691-700
Sun W et al
2006/01/01
PubMed
4 Herberth G et al. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin. Exp. Allergy 2006 Nov;36(11):1408-16
Herberth G et al
2006/01/01
PubMed
5 Fern叩ndez-Mart鱈nez AB et al. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression. Mol. Cell. Endocrinol. 2007 May;270(1-2)
Fern叩ndez-Mart鱈nez AB et al
2007/01/01
PubMed
6 Valdehita A et al. Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. Regul. Pept. 2007 Dec;144(1-3):101-8
Valdehita A et al
2007/01/01
PubMed
7 Herberth G et al. Relation between stressful life events, neuropeptides and cytokines: results from the LISA birth cohort study. Pediatr Allergy Immunol 2008 Dec;19(8):722-9
Herberth G et al
2008/01/01
PubMed
8 Delgado M et al. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Arthritis Rheum. 2008 Apr;58(4):1026-37
Delgado M et al
2008/01/01
PubMed
9 Juarranz Y et al. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Arthritis Rheum. 2008 Apr;58(4):1086-95
Juarranz Y et al
2008/01/01
PubMed
10 Sample SJ et al. Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones. J. Bone Miner. Res. 2008 Sep;23(9):1372-81
Sample SJ et al
2008/01/01
PubMed
  • No.: 1
  • 文献情報:
    Grimsholm O et al. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res. Ther. 2005;7(3):R416-26
    Grimsholm O et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Collado B et al. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. Mol. Cell. Endocrinol. 2006 Apr;249(1-2):116-22
    Collado B et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sun W et al. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis. Int. Immunol. 2006 Dec;18(12):1691-700
    Sun W et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Herberth G et al. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin. Exp. Allergy 2006 Nov;36(11):1408-16
    Herberth G et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fern叩ndez-Mart鱈nez AB et al. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression. Mol. Cell. Endocrinol. 2007 May;270(1-2)
    Fern叩ndez-Mart鱈nez AB et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Valdehita A et al. Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. Regul. Pept. 2007 Dec;144(1-3):101-8
    Valdehita A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Herberth G et al. Relation between stressful life events, neuropeptides and cytokines: results from the LISA birth cohort study. Pediatr Allergy Immunol 2008 Dec;19(8):722-9
    Herberth G et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Delgado M et al. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Arthritis Rheum. 2008 Apr;58(4):1026-37
    Delgado M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Juarranz Y et al. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Arthritis Rheum. 2008 Apr;58(4):1086-95
    Juarranz Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Sample SJ et al. Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones. J. Bone Miner. Res. 2008 Sep;23(9):1372-81
    Sample SJ et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed